Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03122509 |
|---|---|
| Brief Title: | A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer |
| First Submitted : | April 18, 2017 |
| First Submitted that Met QC Criteria : | April 18, 2017 |
| First Posted : | April 20, 2017 |
| Results First Submitted : | April 28, 2022 |
| Results First Posted with QC Comments : | May 24, 2022 |
| Results First Submitted that Met QC Criteria : | June 15, 2022 |
| Results First Posted : | July 6, 2022 |
| Last Update Submitted that Met QC Criteria : | June 15, 2022 |
| Last Update Posted : | July 6, 2022 |